A B S T R A C T This study was designed to determine whether human hearts release adenosine, a possible regulator of coronary flow, during temporary myocardial ischemia and, if so, to examine the mechanisms involved. Release of adenosine from canine hearts had been reported during reactive hyperemia following brief coronary occlusion, and we initially confirmed this observation in six dogs hearts. Angina was then produced in 15 patients with anginal syndrome and severe coronary atherosclerosis by rapid atrial pacing during diagnostic studies. In 13 of these patients, adenosine appeared in coronary sinus blood, at a mean level of 40 nmol/100 ml blood (SE = ±9). In 11 of these 13, adenosine was not detectable in control or recovery samples; when measured, there was concomitant production of lactate and minimal leakage of K+, but no significant release of creatine phosphokinase, lactic acid dehydrogenase, creatine, or Na+.
A B S T R A C T This study was designed to determine whether human hearts release adenosine, a possible regulator of coronary flow, during temporary myocardial ischemia and, if so, to examine the mechanisms involved. Release of adenosine from canine hearts had been reported during reactive hyperemia following brief coronary occlusion, and we initially confirmed this observation in six dogs hearts. Angina was then produced in 15 patients with anginal syndrome and severe coronary atherosclerosis by rapid atrial pacing during diagnostic studies. In 13 of these patients, adenosine appeared in coronary sinus blood, at a mean level of 40 nmol/100 ml blood (SE = ±9). In 11 of these 13, adenosine was not detectable in control or recovery samples; when measured, there was concomitant production of lactate and minimal leakage of K+, but no significant release of creatine phosphokinase, lactic acid dehydrogenase, creatine, or Na+.
There was no detectable release of adenosine by hearts during pacing or exercise in three control groups of patients: nine with anginal syndrome and severe coronary atherosclerosis who did not develop angina or produce lactate during rapid pacing, five with normal coronaries and no myocardial disease, and three with normal coronaries but with left ventricular failure.
The results indicate that human hearts release significant amounts of adenosine during severe regional myocardial ischemia and anaerobic metabolism. Adenosine release might provide a useful supplementary index of the early effects of ischemia on myocardial metabolism, and might influence regional coronary flow during or after angina pectoris. INTRODUCTION In human hearts with restricted coronary circulation, temporary increases in oxygen needs can produce angina pectoris, changes in electrical repolarization, and the release of lactate and potassium into coronary venous blood (1) . In animals, temporary myocardial ischemia has also been shown to cause release of inorganic phosphate (2) as well as adenosine, inosine, and hypoxanthine (3) . The release of adenosine is of particular interest, both as an index of the effects of ischemia on myocardial purines and as a possible regulator of coronary blood flow. Adenosine is a potent coronary vasodilator, has a rich pool of precursors within myocardial cells, readily crosses cell membranes, is quickly degraded, is present in the well oxygenated myocardium at low basal levels, and increases during ischemia (3, 4, 5) . The nucleotide precursors of adenosine are more potent vasodilators (6) , but do not diffuse 'freely from normal cells; the degradation products of adenosine, inosine and hypoxanthine, are diffusible but do not increase coronary flow (3) .
Adenosine appeared in coronary sinus (CS) 1 blood when reactive hyperemia was induced in canine hearts by transient coronary occlusion (3) . Although there is no direct evidence that adenosine increases coronary flow in man, dipyridamole, which inhibits the uptake and degradation of adenosine by cells, is a potent coronary vasodilator (7) .
In these studies, we initially confirmed the observation that, in dogs, adenosine appears in CS blood after transient ischemia, and then we examined an analogous situation in man. In patients with severe coronary athero-sclerosis, we found that adenosine was released in significant amounts when angina and concomitant lactate production were induced by rapid atrial pacing.
METHODS

Studies in dogs
Studies were preliminary and were designed to perfect techniques and to confirm earlier work (3) . CS Control samples of 90 ml of CS blood were collected in an identical fashion for measurement of adenosine, either before pacing or at 10 min after complete recovery from angina. Heart rates during these collections were always at resting levels, and were generally less than half the rate required to produce angina. In two patients with no coronary artery disease who were included as controls, exercise on a bicycle ergometer was substituted for atrial pacing during hemodynamic studies and caused similar increases in heart rate.
For measurement of lactate before, during, and after angina, samples of blood from the CS and the femoral artery were simultaneously collected into cold 6% perchloric acid. Small samples of CS blood were also collected for measurement of CPK, LDH, Cr, cyclic 3',5'-AMP (c-AMP), inorganic phosphate (Pi), Nat, and K+.
Analytic techniques
Rapid processing of blood samples was essential to minimize uptake of adenosine by red cells. The procedure was modified from that described by Rubio, Berne, and Katori (3). The diluted samples of chilled heparinized blood were centrifuged at 40C for 5 min at 1,800g. The supernates were heated at 1000 C for 10 min to denature proteins, which were separated at 24,500g. Samples had to be concentrated considerably because of the low concentrations of adenosine in human blood. The supernate and washings of the precipitates were ultrafiltered through a Diaflo UM-2 membrane (Amicon Corp., Lexington, Mass.) to remove material over mol wt 1,000. This improved adsorption of the nucleosides contained in 90 ml of blood onto 2 g of highly purified Norite A charcoal. The charcoal was collected on a no. 40 Whatman filter and washed with water until free of salts; nucleosides were eluted by shaking in 3% NH40H-60% ethanol for 10 h at 370C. The charcoal was washed with ethanol to remove all material absorbing at 260 nm, and fine particles were removed by filtration through a Millipore membrane. Filtrates were flash-evaporated to dryness and redissolved in 1 or 2 ml of 50% ethanol at pH 10. Either all or one half of this was streaked on thin layer (0/5 mm) plates of the ion exchange resin, Selectacel-P (Schleicher and Schuell, Inc., Keene, N. H.), and developed at 4°C with 15% ethanol at pH 7.0. Separated nucleosides were identified under UV light by their migrations relative to known standards and were eluted. Eluates were lyophilized in test tubes and redissolved in H20 or in 0.05 N NaOH for hypoxanthine. The identity and purity of each eluted streak was confirmed on a second plate by development with 25% ethanol at pH 10. When eluates showed background absorbance which interfered with the spectrophotometric assay, unidentified blood chromagens were further removed by a second development.
Adenosine. Adenosine was measured with a micromodification of the adenosine deaminase technique described by Kalckar (8) . Assays were made with a Beckman D-U spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.), using a reaction mixture of 400 pl and sample volumes of 50 or 100 /Al, representing 1/4 to 1/16 of the original sample. Accurate measurement required changes in absorbance at 260 nm greater than 0/01. The enzymatic technique could precisely measure 1.0 nmol of adenosine. Standards containing 10 nmol of adenosine were measured enzymatically during each experimental assay and were regularly recovered at 90% or more. Duplicate enzymatic assays of all experimental samples agreed to within 10%o. The assay was linear with respect to concentration and was not affected by addition of ATP, ADP, or AMP, which were well separated from adenosine during thin layer chromatography.
65-80%. Studies with ["C] adenosine showed that most losses occurred during elution from charcoal and during flash evaporation.
Adenosine added to human blood. Adenosine added to human blood was recovered in a range of 42-55%, corresponding to the results of others (3). To duplicate experimental conditions, standards were added to saline in the syringes used to collect systemic venous blood. The individual rates of recovery were: (a) 95 nmol/90 ml (four studies): 53 and 50% from duplicate samples; 47 46 and 48% from duplicate samples. Recoveries from whole blood were not improved significantly by addition of dipyridamole alone or in combination with inhibitors of adenosine deaminase such as p-chloromercuribenzoate, 8-azaguanine, or sodium mercaptomerin. Concentrations of adenosine below 10 nmol/100 ml of blood were detectable but could not be reliably measured, despite the sensitivity of the enzymatic assay, because of the high background absorbance of the blood concentrates. No adenosine was detected in systemic venous blood in two duplicate samples of 90 ml or in four separate samples of 40 ml each. Adenosine was not detected in dilute hemolysates prepared from two samples of 10 ml of human blood.
Inosine and hypoxanthine. Inosine and hypoxanthine were qualitatively identified on the thin layer plates but were not regularly eluted and measured enzymatically, since our principal concern was to identify adenosine, the vasoactive nucleoside. Recoveries of 300 nmol standards of these nucleosides from two 90-ml samples of whole blood were 60 and 70%.
Lactate, creatine, and serum Nas and K+. Lactate was measured enzymatically in duplicate samples of deproteinized blood (9) ; the values were-averaged and reported as the conventional lactate extraction ratio, (A-CS/A) X 100. Negative values for this ratio, or a marked shift from previously positive values, indicate production of lactate by the heart. Creatine was measured enzymatically (10) in plasma samples which were rapidly separated from chilled blood, ultrafiltered, and extracted repeatedly with ether to remove pyruvic acid (11) . Results from duplicate samples agreed within 90%. CPK and LDH were measured enzymatically in duplicate (10, 12) . Normal values for LDH were from 100 to 350 U/ml, and for CPK from 0 to 12 U/ml of serum. Serum Na+ and K+ were measured by flame photometry using lithium as an internal standard.;
The levels of these substances in CS blood during angina pectoris were compared with levels found during control or recovery periods in each patient and evaluated both as pairs and in groups by Student's t test.
P4 and c-AMP. Pi was measured in protein-free filtrates of serum by the calorimetric stannous chloride method (13) , with a reproducibility of 95%. c-AMP was measured in deproteinized serum by competitive protein binding (14) ; the normal mean level in systemic venous serum was 39.8 pmol/ml (SE±7.8).
RESULTS
Studies in dogs
In six animals studied during reactive hyperemia, adenosine was found in CS blood at levels similar to those reported by Rubio et al. (3) . Inosine and hypoxanthine were qualitatively identified in all hyperemic samples but were assayed enzymatically in only two studies; the levels again approximated those reported earlier (3). Cr was measured in three animals during reactive hyperemia and was not increased. After Figure 1) . CPK, LDH, and Nat in CS blood did not increase significantly during angina. Potassium was slightly higher in CS blood during angina in 10 of '13 patients in whom paired samples were examined; the differences between paired samples were of borderline significance, with P < 0.05. Arterial levels were not measured. Cr was higher in CS blood during angina in 7 of 13 patients studied, but the increases were not statistically significant. Of four patients examined (no. 8, 9, 10, and 15), only nos. 10 and 15 produced inosine and hypoxanthine during angina and in very small amounts, in contrast to the findings after transient ischemia in dogs (3).
Pi and c-AMP. Pi was measured in CS plasma from patients 8, 9, and 15 and was increased slightly during angina. Control values were 2.5, 1.6, and 1.9 mg/100 ml serum; during angina the corresponding values were 3.2, 3.0, and 2.7 mg/100 ml serum.
c-AMP was measured in CS blood in patients 9, 10, and 15 and was unchanged during angina. Control values were 44.2, 40, and 32.4 pmol/ml; during angina, the values were 42, 42, and 32.4 pmol/ml, respectively.
Control groups GROUP B
Nine patients with histories of angina pectoris and with significant obstructive coronary artery disease developed no angina or only questionable angina during atrial pacing equivalent to or exceeding the rates and durations which caused angina in the preceding group. None of these patients produced significant amounts of rate at which it was induced are indicated in parentheses. Conthan one-half the paced rates.
lactate, and none released detectable levels of adenosine (Table II) . No significant changes occurred during pacing in CS levels of LDH, CPK, Cr, Na', or Ki (Table II) . In patient no. 8, control blood contained 51 pmol c-AMP/ml and 2.7 mg Pi/100 ml; with pacing, the levels were unchanged, at 51 pmol c-AMP/ml and 2.9 mg Pi/100 ml.
Patients 2, 3, and 6 had severe stenoses of three major coronary arteries; patients 1 and 9 had severe stenoses of two; patients 7 and 8 had severe stenosis of one major artery. Patient 6 had recurrent angina despite previous direct myocardial implantation of both internal mammary arteries. The extent of coronary artery disease in these seven patients did not, therefore, differ substantially from that in the patients of group A (Table  I) apparently minimized by rapid collection and processing of blood. Since we did not detect significant amounts of inosine or hypoxanthine in man, it is possible that these nucleosides were not released in the amounts found in dogs (3) and that degradation of adenosine was not the cause of the systematic 50% losses from whole blood. Because of the limits of sensitivity of the analytic methods, it is impossible to state that adenosine was totally absent from CS blood obtained before angina or after recovery, or from the control groups at rest or during pacing and exercise. In the latter groups it is possible that increases in total coronary flow may have caused dilution of whatever adenosine was released to undetectable levels. These data do not, therefore, permit conclusions as to the physiologic role of adenosine as a metabolic vasoregulator in normal hearts. However, the release of adenosine from arteriosclerotic hearts during induction of severe regional ischemia was definite.
The appearance of adenosine in CS blood during angina probably reflected increased concentrations of the nucleoside in the myocardium. Direct measurements ot is indicated in parentheses.
adenosine levels in dog hearts have shown that coronary occlusions for 15 s raised regional concentrations from 0/32 to 1.82 nmol/g, (5); in rats, levels rose from 6 to 128 nmol/g after 20 min of ischemia (17) . If the levels of adenosine found in CS blood during angina are corrected for losses during analysis, calculated estimates of corresponding levels in myocardial interstitial fluid approach or exceed 56 nmol/100 ml, a level which produced maximum increases in 'blood flow in dogs after intracoronary injection (3) .
During angina pectoris, the wide variation in levels of adenosine and lactate in CS blood could have reflected true differences in release of these substances or variable sampling due to the positions of catheters relative to coronary veins draining ischemic and nonischemic areas (18) . It was not unexpected that some patients with histories of angina and with significant coronary stenoses did not develop angina during prolonged pacing. Patients with similar patterns of major coronary arterial stenoses often have different thresholds to angina (19 individuals in the mass of ischemic tissue, in collateral circulation, in patterns of nutrient flow, or in regional metabolic requirements. It is not clear whether the release of adenosine from the myocardium during ischemia reflects increased production of adenosine or leakage due to a specific increase in cell-wall permeability. Lactate production during ischemia probably reflects an increase in production and in transmembrane concentration gradients (20) . Our findings indicate that there is at least a temporal relationship between ischemia, adenosine release, and lactate production. The absence of concomitant release of cytoplasmic enzymes suggests only that major damage to cell membranes was unlikely. Since patients with manifest left ventricular failure and normal coronary arteries did not produce adenosine, it was also unlikely that ventricular failure, per se, caused adenosine release during angina.
The release of adenosine during angina may prove useful as a sensitive supplemental index of the effects of regional ischemia on myocardial metabolism in clinical situations such as unstable angina or questionable infarction. Regional ischemia causes a prompt change in cell membrane potential, a loss of K+, a shift to anaerobiosis with production of lactate, and, as high energy phosphates are hydrolyzed, a loss of orthophosphate (1, 2) . The increases we found in orthophosphate during angina in three patients permit no definite conclusions, but are consistent with changes noted in venous blood from ischemic canine hearts (2) . Similarly, we measured Cr in CS blood as a possible index of increased intracellular levels of diffusible free Cr, produced early in ischemia by rapid hydrolysis of CrP, which is not diffusible (21, 22) . Although there was a trend to release of Cr during angina, the increases were not statistically significant. Fig. 2 depicts some of the processes which may regulate adenosine levels in the myocardial cell. A fall in regional levels of ATP during ischemia (22, 23, 24) aminase (25, 26) . Activity of 5'-nucleotidase is highest at cell walls and in perivascular cells (27, 28) . Adenosine produced in these areas may dilate resistance vessels and then may be metabolized rapidly by red cell adenosine deaminase, removed by the venous effluent, or returned to myocardial cells by facilitated diffusion (29) . During recovery from myocardial ischemia, the synthesis of nucleotides increases, perhaps to compensate for prior losses (30) . The mechanism by which adenosine dilates coronary arteries is not clear. Adenosine is probably one of many metabolic vasoregulators which act in concert to relax vascular smooth muscle in response to increased myocardial oxygen needs (31) . The action of adenosine is potentiated by low Po2 (32, 33) and may be mediated by "purinergic" nerve endings (34) . It does not cause increased myocardial oxygen consumption, and high concentrations are negatively inotropic (35, 36) . Although high levels of adenosine inhibit 3',5'-phosphodiesterase (37), we found no increases in c-AMP in coronary venous blood samples taken at the time of adenosine release. The role of adenosine as a metabolic vasoregulator has been questioned, since neither aminophylline, a blocker of the vasodilator effects of infused adenosine, nor lidoflazine, a potentiator, altered postischemic reactive hyperemia (38) ; but these drugs may not reach the intracellular sites of endogenous adenosine production.
During angina, the pattern of changes in total coronary flow and its intramyocardial distribution are not well established; these were not examined during adenosine release in this study. Total coronary flow may increase during induced angina, perhaps as flow is increased to marginally ischemic areas by metabolically induced vasodilators (39) , or it may decrease (40, 41) . Recent investigations with precordial imaging techniques suggest that regional flow to the most ischemic areas may decrease during angina (42, 43) .
The release of adenosine found in both man and dog (3) was related to transient myocardial ischemia produced by different but analogous means. Rapid pacing in man induced angina by increasing myocardial oxygen needs in the presence of severe restrictions to coronary flow. Reactive hyperemia was induced in dogs by temporary restriction of coronary flow, but the hyperemic response, like angina, is related to heart rate and oxygen consumption (35, 44) and is accompanied by lactate production (45) . Reactive hyperemia has also been demonstrated in human hearts after brief occlusion and release of functioning coronary artery bypass grafts during surgery (46, 47) .
It seems reasonable to speculate that if adenosine is truly an effective vasodilator in man, the large amounts released during, and perhaps immediately after, induced angina may have physiologic effects. Adenosine released from ischemic areas, where vasodilation is already maximal, may diffuse to marginally ischemic zones where the resultant increase in blood flow may help protect jeopardized cells. Similarly, as the reversible ischemia of angina subsides, washout of adenosine might augment regional flow and delivery of oxygen and might expedite removal of accumulated metabolites in a pattern analogous to reactive hyperemia in the dog. Improved methods for analysis of adenosine in smaller samples of blood (48) may permit more precise assessment in man of the sequential relationships between acute ischemia, evidence of anaerobic metabolism, the release of adenosine, and possible changes in regional myocardial perfusion.
